Rise Advisors’s Boston Scientific BSX Stock Holding History

Rise Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-873	Closed	-$85.2K	–	295
2025 Q3	$85.2K	Buy	873 +32	+4%	+$3.31K	0.03%	177
2025 Q2	$90.3K	Sell	841 -3	-0.4%	-$304	0.04%	163
2025 Q1	$85.1K	Buy	844 +103	+14%	+$10.4K	0.04%	163
2024 Q4	$66.2K	Buy	741 +10	+1%	+$880	0.03%	184
2024 Q3	$61.3K	Hold	731	–	–	0.03%	205
2024 Q2	$56.3K	Hold	731	–	–	0.03%	218
2024 Q1	$50.1K	Buy	+731	New	+$47K	0.03%	233

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Rise Advisors's BSX Position: Q4 2025 in Review

Rise Advisors sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 873 shares — an estimated $85.2K sold.

Rise Advisors first reported a position in BSX in Q1 2024 and held it in 7 quarters. The position peaked at $90.3K in Q2 2025. 1,795 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

Rise Advisors reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
Rise Advisors sold 873 Boston Scientific shares in Q4 2025, an estimated $85.2K.
Rise Advisors first reported a position in Boston Scientific in Q1 2024 and held it in 7 quarters.
Rise Advisors's Boston Scientific position peaked at $90.3K in Q2 2025.
1,795 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.